The Ito Liver Model and the Ito Multi-organ Model are used in conjunction and constitute an efficient and rapid bioassay for the identification of both genotoxic and nongenotoxic carcinogenic chemicals. The Ito Liver Model is an 8-week bioassay system that uses the number and size of foci of hepatocytes positive for glutathione S-transferase placental form (GST-P) as the end-point marker. One hundred fifty-nine compounds were tested using the Ito Liver Model: 61 of 66 hepatocarcinogens tested positive, and 10 of 43 nonliver carcinogens were also positive. The false-positive detection of noncarcinogens was low; a single false-positive result was obtained from the 50 noncarcinogens tested. Since more than half of all known carcinogens are hepatocarcinogens in rodents, the initial 8-week bioassay is able to detect most carcinogens. The Ito Multi-organ Model is a 28-week bioassay system for the detection of carcinogens that were not identified by the Ito Liver Model. Results are evaluated by preneoplastic and neoplastic lesions in major organs. Forty-four compounds were tested using the Ito Multi-organ Model: 17 out of 17 liver carcinogens were positive, and 19 out of 22 (86%) nonliver carcinogens were positive. None of the five noncarcinogens tested positive.
Akagi, K., Hirose, M., Hoshiya, T., Mizoguchi, Y., Ito, N., and Shirai, T. ( 1995). Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett94, 113-21.
2.
Ashby, J., and Tennant, R.W. ( 1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP . Mutat Res257, 229-306.
3.
Bannasch, P. ( 1986). Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis7, 689-95.
4.
Cooper, J.A., 2nd, Saracci, R., and Cole, P. ( 1979). Describing the validity of carcinogen screening tests . Br J Cancer39, 87-89.
5.
Fukushima, S., Hagiwara, A., Hirose, M., Yamaguchi, S., Tiwawech, D., and Ito, N. ( 1991). Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats. Jpn J Cancer Res82, 642-49.
6.
Hagiwara, A., Tanaka, H., Imaida, K., Tamano, S., Fukushima, S., and Ito, N. ( 1993). Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats. Jpn J Cancer Res84, 237-45.
7.
Hasegawa, R., and Ito, N. ( 1992). Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. Food Chem Toxicol30, 97992.
8.
Higginson, G., and Anderson, R. ( 1931). Experimental pathology of the liver. 1. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol12, 186-202.
9.
ICH Steering Committee, I. (1997). International Conference on Harmonization: Carcinogenicity: testing for carcinogenicity of pharmaceuticals. In Proceedings of Fourth International Conference on Harmonization.
10.
Ito, N., Hasegawa, R., Imaida, K., Hirose, M., and Shirai, T. ( 1996). Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp Toxicol Pathol48, 113-19.
11.
Ito, N., Hasegawa, R., Imaida, K., Hirose, M., Shirai, T., Tamano, S., and Hagiwara, A. ( 1997). Medium-term rat liver bioassay for rapid detection of hepatocarcinogenic substances. J Toxicol Pathol1-11.
12.
Ito, N., Hasegawa, R., Imaida, K., Masui, T., Takahashi, S., and Shirai, T. ( 1992). Pathological markers for non-genotoxic agent-associated carcinogenesis. Toxicol Lett64, 613-20.
13.
Ito, N., Tamano, S., and Shirai, T. ( 2003). A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci94, 3-8.
14.
Kitahara, A., Satoh, K., Nishimura, K., Ishikawa, T., Ruike, K., Sato, K., Tsuda, H., and Ito, N. ( 1984). Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis. Cancer Res44, 2698-2703.
15.
Liu, L.L., Gong, L.K., Qi, X.M., Cai, Y., Wang, H., Wu, X.F., Xiao, Y., and Ren, J. ( 2005). Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis . Acta Pharmacol Sin26, 737-44.
16.
Matsumoto, K., and Nakamura, T. ( 1992). Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog3, 27-54.
17.
Oesterle, D., and Deml, E. ( 1990). Detection of chemical carcinogens by means of the ‘‘rat liver foci bioassay.’’ Exp Pathol39, 197-206.
18.
Ogawa, K., Yokokawa, K., Tomoyori, T., and Onoe, T. ( 1982). Induction of gamma-glutamyltranspeptidase-positive altered hepatocytic lesions by combination of transplacental-initiation and postanal-selection . Int J Cancer29, 333-6.
19.
Ogiso, T., Tatematsu, M., Tamano, S., Tsuda, H., and Ito, N. ( 1985). Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and of hepatocellular carcinomas in a long-term assay. Toxicol Pathol13, 257-65.
20.
Peraino, C., Fry, R.J., Staffeldt, E., and Christopher, J.P. (1975). Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res35, 2884-90.
21.
Peraino, C., Fry, R.J., Staffeldt, E., and Christopher, J.P. (1977). Enhancing effects of phenobarbitone and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Food Cosmet Toxicol15, 93-96.
22.
Peraino, C., Staffeldt, E.F., Haugen, D.A., Lombard, L.S., Stevens, F.J., and Fry, R.J. ( 1980). Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis . Cancer Res40, 3268-273.
23.
Pitot, H., and Dragan, Y. ( 2001). Chemical carcinogenesis. In Casertt & Doul’s TOXICOLOGY: The basic science of poisons, 6th ed. (I. K. Cd, ed.), pp. 241-319. McGraw-Hill , New York.
24.
Shirai, T. ( 1997). A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: A historical review of model development and summary of results from 291 tests. Toxicol Pathol25, 453-60.
25.
Shirai, T., Hirose, M., and Ito, N. ( 1999). The use of short-and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Consensus report. InIARC Sci Publ, pp. 1-18.
26.
Solt, D., and Farber, E. ( 1976). New principle for the analysis of chemical carcinogenesis . Nature263, 701-3.
27.
Tatematsu, M., Mera, Y., Ito, N., Satoh, K., and Sato, K. ( 1985). Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis6, 1621-26.
28.
Tatematsu, M., Shirai, T., Tsuda, H., Miyata, Y., Shinohara, Y., and Ito, N. ( 1977). Rapid production of hyperplastic liver nodules in rats treated with carcinogenic chemicals: a new approach for an in vivo short-term screening test for hepatocarcinogens. Gann68, 499-507.
29.
Tsuda, H., Asamoto, M., Iwahori, Y., Hori, T., Ota, T., Baba-Toriyama, H., Uehara, N., Kim, D.J., Krutovskikh, V.A., Takasuka, N., et al. (1996). Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver. Carcinogenesis17, 2441-48.
30.
Tsuda, H., Fukushima, S., Wanibuchi, H., Morimura, K., Nakae, D., Imaida, K., Tatematsu, M., Hirose, M., Wakabayashi, K., and Moore, M.A. ( 2003). Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: Evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work . Toxicol Pathol31, 80-86.
31.
Tsuda, H., Hasegawa, R., Imaida, K., Masui, T., Moore, M.A., and Ito, N. ( 1984). Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver. Gann75, 876-83.
32.
Tsuda, H., Lee, G., and Farber, E. ( 1980). Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res40, 1157-64.
33.
Tsuda, H., Moore, M.A., Asamoto, M., Inoue, T., Ito, N., Satoh, K., Ichihara, A., Nakamura, T., Amelizad, Z., and Oesch, F. ( 1988). Effect of modifying agents on the phenotypic expression of cytochrome P-450, glutathione Stransferase molecular forms, microsomal epoxide hydrolase, glucose-6-phosphate dehydrogenase and gamma-glutamyltranspeptidase in rat liver preneoplastic lesions. Carcinogenesis9, 547-54.
34.
Tsuda, H., Moore, M.A., Asamoto, M., Satoh, K., Tsuchida, S., Sato, K., Ichihara, A., and Ito, N. ( 1985). Comparison of the various forms of glutathione S-transferase with glucose-6-phosphate dehydrogenase and gamma-glutamyltranspeptidase as markers of preneoplastic and neoplastic lesions in rat kidney induced by N-ethyl-N-hydroxyethylnitrosamine . Jpn J Cancer Res76, 919-29.
35.
Tsuda, H., Ozaki, K., Uwagawa, S., Yamaguchi, S., Hakoi, K., Aoki, T., Kato, T., Sato, K., and Ito, N. ( 1992). Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats. Jpn J Cancer Res83, 1154-65.
36.
Ward, J.M., Tsuda, H., Tatematsu, M., Hagiwara, A., and Ito, N. ( 1989). Hepatotoxicity of agents that enhance formation of focal hepatocellular proliferative lesions (putative preneoplastic foci) in a rapid rat liver bioassay. Fundam Appl Toxicol12, 163-71.
